Oncology & Cancer

Scientists narrow in on cells that drive immune response to cancer

Immunotherapy, using the body's own immune system to target and destroy cancer cells, is one of the most promising frontiers in cancer research, but many patients do not respond to the therapies for reasons not fully understood.

Oncology & Cancer

Study reveals new insight into tumor progression

Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.

Neuroscience

No genetic clock for neuron longevity

(Medical Xpress)—People are living longer than ever before, thanks to medical and technological advances. Unfortunately, aging can be associated with a decrease in brain function. This is because, unlike other cells in ...

Oncology & Cancer

New clues about the risk of cancer from low-dose radiation

Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) have uncovered new clues about the risk of cancer from low-dose radiation, which in this research they define as equivalent ...

Oncology & Cancer

Cancer: The immune system attacks tumors remotely

How does the immune system act to limit tumor development? Using in vivo imaging tools, scientists from the Institut Pasteur and Inserm described the spatiotemporal activity of tumor-infiltrating T lymphocytes, both locally ...

page 2 from 21